Patient reports after treatment for vascular malformations
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how patients feel after a procedure used to treat vascular malformations (abnormal blood vessel growth). You may be asked to complete questionnaires about symptoms and quality of life before and after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a vascular malformation diagnosis (abnormal blood vessel growth).
- If you are a child, you are 0–17 years old; if an adult, you are 18–100.
- Your symptoms are significant enough that you’re already seeking treatment for the vascular malformation.
- Your vascular malformation is appropriate for sclerotherapy (a type of injection-based treatment), not too extensive.
- You have not had any treatment for the vascular malformation within the last 3 months.
- You’re able to take part in the study activities (for example, you have the ability to complete forms or report symptoms).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment that uses microwave energy to shrink painful or troublesome abnormal blood vessels (vascular malformations). It may help reduce symptoms like pain and swelling without open surgery.
This study tests a drug called everolimus to see if it helps treat vascular malformations (abnormal clusters of blood vessels). It is for adults aged 18 to 65 who have been diagnosed by MRI and are able to take oral medication.
This study looks at how brain arteriovenous malformations (abnormal connections between arteries and veins in the brain) behave over time, and how different treatment choices affect outcomes. It may help researchers better predict prognosis and guide future care.
This study tests whether new imaging techniques (called MSOT and ULM) can better see vascular malformations. It may help doctors diagnose and understand these conditions without the need for risky procedures.
This study looks at how people with abnormal blood vessel or lymph vessel growths are treated in everyday medical practice with certain medicines called mTOR, PI3K, and MEK inhibitors. It aims to learn more about how these treatments work in real life to help doctors make better decisions.
This trial tests whether the study drug KP-001 can help reduce symptoms like pain, fatigue, or bleeding caused by certain vascular malformations (abnormal blood vessel growths) that can't be surgically removed or haven't responded to other treatments. It's for people age 2 and older with specific conditions such as common venous malformations, lymphatic malformations, or KTS/CLOVES syndrome.
Hear when a new Vascular Malformations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.